NO982729L - Antagonister av det gonadotropinfrigj°rende hormon - Google Patents
Antagonister av det gonadotropinfrigj°rende hormonInfo
- Publication number
- NO982729L NO982729L NO982729A NO982729A NO982729L NO 982729 L NO982729 L NO 982729L NO 982729 A NO982729 A NO 982729A NO 982729 A NO982729 A NO 982729A NO 982729 L NO982729 L NO 982729L
- Authority
- NO
- Norway
- Prior art keywords
- antagonists
- gonadotropin
- releasing hormone
- useful
- conditions
- Prior art date
Links
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 title 1
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 title 1
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 title 1
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US863395P | 1995-12-14 | 1995-12-14 | |
| GBGB9603242.0A GB9603242D0 (en) | 1996-02-16 | 1996-02-16 | Antagonists of gonadotropin releasing hormone |
| PCT/US1996/019444 WO1997021704A1 (en) | 1995-12-14 | 1996-12-10 | Antagonists of gonadotropin releasing hormone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO982729D0 NO982729D0 (no) | 1998-06-12 |
| NO982729L true NO982729L (no) | 1998-08-13 |
Family
ID=26308721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO982729A NO982729L (no) | 1995-12-14 | 1998-06-12 | Antagonister av det gonadotropinfrigj°rende hormon |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0873336B1 (et) |
| JP (2) | JP3230818B2 (et) |
| KR (1) | KR19990072101A (et) |
| CN (1) | CN1208412A (et) |
| AT (1) | ATE215081T1 (et) |
| AU (1) | AU707641B2 (et) |
| CA (1) | CA2240108A1 (et) |
| CZ (1) | CZ183998A3 (et) |
| DE (1) | DE69620241T2 (et) |
| EA (1) | EA000992B1 (et) |
| EE (1) | EE9800173A (et) |
| ES (1) | ES2174129T3 (et) |
| HU (1) | HUP9903671A3 (et) |
| IL (1) | IL124459A0 (et) |
| NO (1) | NO982729L (et) |
| NZ (1) | NZ325569A (et) |
| PL (1) | PL327146A1 (et) |
| SK (1) | SK77298A3 (et) |
| WO (1) | WO1997021704A1 (et) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI114793B (fi) | 1994-04-01 | 2004-12-31 | Lilly Co Eli | 1H-indoli-glyoksyyliamidi-sPLA2-inhibiittoreita |
| US6200957B1 (en) | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU704937B2 (en) * | 1995-12-14 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1998055123A1 (en) * | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| EP0986557A4 (en) * | 1997-06-05 | 2001-03-14 | Merck & Co Inc | GONADOLIBERIN ANTAGONISTS |
| EP0986385A4 (en) * | 1997-06-05 | 2001-05-16 | Merck & Co Inc | GONADOLIBERINE ANTAGONISTS |
| WO1999021557A1 (en) * | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6017944A (en) * | 1997-10-28 | 2000-01-25 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CA2308454A1 (en) * | 1997-10-28 | 1999-05-06 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU2597899A (en) * | 1998-02-11 | 1999-08-30 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5972898A (en) * | 1998-03-27 | 1999-10-26 | Abbott Laboratories | 3',3-N-bis-substituted macrolide LHRH antagonists |
| US5955440A (en) * | 1998-03-27 | 1999-09-21 | Abbott Laboratories | Macrolide LHRH antagonists |
| CA2326143A1 (en) * | 1998-04-02 | 1999-10-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| DE19815060A1 (de) * | 1998-04-03 | 1999-10-14 | Jenapharm Gmbh | Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie |
| US6387885B1 (en) * | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
| US6020521A (en) * | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
| US6346534B1 (en) | 1998-09-23 | 2002-02-12 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| US5981521A (en) * | 1998-11-13 | 1999-11-09 | Abbott Laboratories | Tetrahydroisoquinoline derivatives as LHRH antagonists |
| US6537998B1 (en) | 1999-10-15 | 2003-03-25 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| KR100814269B1 (ko) | 2000-01-25 | 2008-03-18 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 고나도트로핀-분비 호르몬 수용체 길항제 및 이를 포함하는 약제학적 조성물 |
| GB0022670D0 (en) | 2000-09-15 | 2000-11-01 | Astrazeneca Ab | Molecules |
| SE0100566D0 (sv) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| SE0101692D0 (sv) | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
| WO2003011841A1 (en) | 2001-08-02 | 2003-02-13 | Neurocrine Biosciences, Inc. | 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| US6740656B2 (en) | 2001-08-02 | 2004-05-25 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| US6750350B2 (en) | 2001-08-02 | 2004-06-15 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| MXPA04000985A (es) | 2001-08-02 | 2005-02-17 | Neurocrine Biosciences Inc | Piridin-4-onas sustituidas y su uso como antagonistas del receptor de hormona de liberacion de gonadotropina. |
| WO2003068769A1 (en) | 2002-02-12 | 2003-08-21 | Pfizer Inc. | Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh) |
| MXPA04012566A (es) | 2002-06-13 | 2005-04-19 | Pfizer | Agentes no peptidicos reguladores de la gnrh, composiciones farmaceuticas y procedimientos para su uso. |
| KR100378891B1 (ko) | 2002-08-09 | 2003-04-08 | 에스케이 텔레콤주식회사 | 플렉시블 페이징시의 가입자 기반 링백톤 서비스 방법 |
| KR100392768B1 (ko) | 2002-08-09 | 2003-07-28 | 에스케이 텔레콤주식회사 | 발신 교환기를 이용한 가입자 기반 링백톤 서비스 방법 |
| TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
| ATE363481T1 (de) | 2002-08-21 | 2007-06-15 | Astrazeneca Ab | Pyrazolderivate als gnrh-inhibitoren |
| ATE384066T1 (de) | 2002-08-21 | 2008-02-15 | Astrazeneca Ab | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren |
| GB0219472D0 (en) | 2002-08-21 | 2002-10-02 | Astrazeneca Ab | Chemical compounds |
| TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
| WO2004023833A1 (en) * | 2002-09-05 | 2004-03-18 | Sk Telecom Co., Ltd. | Method of managing trunk and querying and ascertaining ring-back sound to provide ring-back sound in subscriber-based ring-back sound service |
| US7045527B2 (en) | 2002-09-24 | 2006-05-16 | Amgen Inc. | Piperidine derivatives |
| KR100393552B1 (ko) | 2002-10-01 | 2003-08-02 | 에스케이 텔레콤주식회사 | 교환기 음원 송출을 통한 가입자 기반 링백톤 서비스 방법 |
| AU2003251219A1 (en) * | 2002-10-01 | 2004-04-23 | Sk Telecom Co., Ltd | Method for providing a subscriber-based ringback tone sound |
| KR100393553B1 (ko) | 2002-10-18 | 2003-08-02 | 에스케이 텔레콤주식회사 | 착신 미가입자에 대한 발신시 가입자 기반 링백톤 서비스방법 |
| WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| ES2387495T3 (es) | 2003-07-07 | 2012-09-25 | Neurocrine Biosciences, Inc. | Arilpirimidinas útiles en el tratamiento de trastornos relacionados con las hormonas sexuales, tales como endometriosis, cáncer de próstata y similares |
| CN100376246C (zh) | 2003-07-07 | 2008-03-26 | 纽罗克里生物科学有限公司 | 作为促性激素释放激素受体拮抗剂的嘧啶-2,4-二酮衍生物 |
| PT1646389E (pt) * | 2003-07-07 | 2008-12-19 | Neurocrine Biosciences Inc | Derivados de pirimidina-2,4-diona utilizados como antagonistas do receptor da hormona libertadora de gonadotropina |
| NZ551077A (en) | 2004-05-07 | 2009-05-31 | Janssen Pharmaceutica Nv | Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| JP5208505B2 (ja) | 2004-08-30 | 2013-06-12 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | １１−ベータヒドロキシステロイドデヒドロゲナーゼ阻害剤としてのｎ−２アダマンタニル−２−フェノキシ−アセトアミド誘導体 |
| DE602005017159D1 (de) | 2004-08-30 | 2009-11-26 | Janssen Pharmaceutica Nv | Oxysteroid-dehydrogenase-inhibitoren |
| US8563591B2 (en) | 2004-08-30 | 2013-10-22 | Janssen Pharmaceutica N.V. | Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| DE602007006990D1 (de) | 2006-12-07 | 2010-07-15 | Hoffmann La Roche | Spiropiperidinderivate als antagonisten des via-rezeptors |
| US20080153863A1 (en) | 2006-12-22 | 2008-06-26 | Caterina Bissantz | Spiropiperidine derivatives |
| MX2009010296A (es) * | 2007-04-18 | 2009-12-14 | Kissei Pharmaceutical | Derivado de anillo fusionado nitrogenado, composicion farmaceutica que lo contiene, y uso del mismo para propositos medicos. |
| BRPI0907577A2 (pt) | 2008-02-22 | 2015-07-21 | Hoffmann La Roche | Moduladores para amiloide beta |
| JP5502089B2 (ja) | 2008-10-09 | 2014-05-28 | エフ．ホフマン−ラ ロシュ アーゲー | アミロイドβのモジュレーター |
| JP5378532B2 (ja) | 2008-11-10 | 2013-12-25 | エフ．ホフマン−ラ ロシュ アーゲー | 複素環γ−セクレターゼモジュレーター |
| TW201130854A (en) | 2009-12-22 | 2011-09-16 | Bayer Schering Pharma Ag | Pyridinone derivatives and pharmaceutical compositions thereof |
| US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| WO2012175514A1 (en) | 2011-06-21 | 2012-12-27 | Bayer Intellectual Property Gmbh | Pyridinone derivatives and pharmaceutical compositions thereof |
| CN102260208A (zh) * | 2011-07-28 | 2011-11-30 | 海门慧聚药业有限公司 | 4-吡啶丁醇的制备新工艺 |
| EP2736330A4 (en) * | 2011-07-29 | 2015-05-27 | Tempero Pharmaceuticals Inc | COMPOUNDS AND METHODS |
| CA2958939A1 (en) | 2014-08-26 | 2016-03-03 | Betanien Hospital | Methods, agents and compositions for treatment of inflammatory conditions |
| JP7462569B2 (ja) | 2017-12-12 | 2024-04-05 | クィーンズ ユニバーシティー アット キングストン | Ｃｙｐ２６酵素を阻害するための化合物および方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
| US4544663A (en) * | 1984-05-07 | 1985-10-01 | Sandoz, Inc. | Indolamine derivatives as anti-fertility agents |
| US5030640A (en) * | 1989-01-05 | 1991-07-09 | Merck & Co., Inc. | Novel β-adrenergic agonists and pharmaceutical compositions thereof |
| TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
-
1996
- 1996-12-10 PL PL96327146A patent/PL327146A1/xx unknown
- 1996-12-10 EE EE9800173A patent/EE9800173A/et unknown
- 1996-12-10 DE DE69620241T patent/DE69620241T2/de not_active Expired - Fee Related
- 1996-12-10 NZ NZ325569A patent/NZ325569A/xx unknown
- 1996-12-10 EA EA199800563A patent/EA000992B1/ru not_active IP Right Cessation
- 1996-12-10 HU HU9903671A patent/HUP9903671A3/hu unknown
- 1996-12-10 CA CA002240108A patent/CA2240108A1/en not_active Abandoned
- 1996-12-10 CN CN96199872A patent/CN1208412A/zh active Pending
- 1996-12-10 KR KR1019980704413A patent/KR19990072101A/ko not_active Application Discontinuation
- 1996-12-10 WO PCT/US1996/019444 patent/WO1997021704A1/en active IP Right Grant
- 1996-12-10 JP JP52212497A patent/JP3230818B2/ja not_active Expired - Fee Related
- 1996-12-10 ES ES96944249T patent/ES2174129T3/es not_active Expired - Lifetime
- 1996-12-10 SK SK772-98A patent/SK77298A3/sk unknown
- 1996-12-10 AU AU14106/97A patent/AU707641B2/en not_active Ceased
- 1996-12-10 CZ CZ981839A patent/CZ183998A3/cs unknown
- 1996-12-10 EP EP96944249A patent/EP0873336B1/en not_active Expired - Lifetime
- 1996-12-10 IL IL12445996A patent/IL124459A0/xx unknown
- 1996-12-10 AT AT96944249T patent/ATE215081T1/de not_active IP Right Cessation
-
1998
- 1998-06-12 NO NO982729A patent/NO982729L/no not_active Application Discontinuation
-
2000
- 2000-08-28 JP JP2000257791A patent/JP2001106685A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9903671A2 (hu) | 2001-10-28 |
| KR19990072101A (ko) | 1999-09-27 |
| CA2240108A1 (en) | 1997-06-19 |
| NZ325569A (en) | 2000-05-26 |
| MX9804765A (es) | 1998-10-31 |
| EP0873336A1 (en) | 1998-10-28 |
| PL327146A1 (en) | 1998-11-23 |
| JPH11506471A (ja) | 1999-06-08 |
| JP3230818B2 (ja) | 2001-11-19 |
| JP2001106685A (ja) | 2001-04-17 |
| AU1410697A (en) | 1997-07-03 |
| AU707641B2 (en) | 1999-07-15 |
| DE69620241D1 (de) | 2002-05-02 |
| EA000992B1 (ru) | 2000-08-28 |
| WO1997021704A1 (en) | 1997-06-19 |
| CN1208412A (zh) | 1999-02-17 |
| ATE215081T1 (de) | 2002-04-15 |
| EA199800563A1 (ru) | 1998-12-24 |
| DE69620241T2 (de) | 2002-10-02 |
| IL124459A0 (en) | 1998-12-06 |
| HUP9903671A3 (en) | 2001-11-28 |
| NO982729D0 (no) | 1998-06-12 |
| ES2174129T3 (es) | 2002-11-01 |
| EE9800173A (et) | 1998-12-15 |
| CZ183998A3 (cs) | 1998-10-14 |
| SK77298A3 (en) | 1999-01-11 |
| EP0873336B1 (en) | 2002-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO982729L (no) | Antagonister av det gonadotropinfrigj°rende hormon | |
| NO982730L (no) | Antagonister av det gonadotropinfrigj°rende hormon | |
| NO982731L (no) | Antagonister av gonadotropinfrigivende hormon | |
| MY133571A (en) | Compositions and methods for treating conditions responsive to estrogen. | |
| NO20033732L (no) | N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser. | |
| NO20025601L (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
| JO3404B1 (ar) | تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين | |
| CA2396159A1 (en) | Novel substituted benzimidazole dosage forms and method of using same | |
| HK1080459A1 (en) | Novel pyrimidineamide derivatives and the use thereof | |
| AU3846901A (en) | Oral, nasal and pulmonary dosage formualtions of copolymer 1 | |
| DE60205455D1 (de) | Naphthyridinderivate | |
| BR0312563A (pt) | Comprimido de lasofoxifeno e seu revestimento | |
| ATE248832T1 (de) | Antagonisten des gonadotropin freisetzenden hormons | |
| MXPA03010761A (es) | Combinaciones farmaceuticas. | |
| DE60025848D1 (en) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
| ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
| MY128896A (en) | Pharmaceutical combinations | |
| NO20003694L (no) | VLA-4 antagonister | |
| HUP0300972A2 (hu) | Gatifloxacin-pentahidrát | |
| CA2364178A1 (en) | N-benzenesulfonyl l-proline compounds as bradykinin antagonists | |
| MXPA04005809A (es) | Inhibidores de proteinas quinasas. | |
| TW200503709A (en) | Itching treating agent containing piperidine derivative as active ingredient | |
| MXPA02008870A (es) | Novedosos antagonistas de lhrh, produccion de los mismos y sus uso como medicamentos. | |
| MXPA02012574A (es) | Uso novedoso de los antagonistas ii de angiotensina. | |
| SE9902596D0 (sv) | Pharmaceutically active compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |